DXCM vs INFU · P/E 63, rev $2.50B vs P/E 25, rev $70.6M
DexCom Inc (DXCM) versus InfuSystems Holdings Inc (INFU) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
InfuSystems Holdings Inc (INFU) is a medical devices company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported INFU revenue for 2026-06-30 was $70.6M. Net income was $4.2M. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
Not investment advice. Open the DXCM and INFU stock pages for the full models.
Not investment advice.